Prevalence and clinical associations of calcium-sensing receptor and NALP5 autoantibodies in finnish APECED patients

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 3, 2014, Pages 1064-1071

  Kemp, E Helen ^a   Habibullah, Mahmoud ^a   Kluger, Nicolas ^b   Ranki, Annamari ^b   Sandhu, Harpreet K ^a   Krohn, Kai J E ^c   Weetman, Anthony P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCIUM SENSING RECEPTOR; CYTOKINE; CYTOKINE ANTIBODY; GENOMIC DNA; NALP5 AUTOANTIBODY; PARATHYROID AUTOANTIBODY; RADIOLIGAND; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; BINDING ASSAY; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; FINNISH; GENE MUTATION; HUMAN; HYPOPARATHYROIDISM; IMMUNOPRECIPITATION; MALE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOANTIGENS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FINLAND; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; POLYENDOCRINOPATHIES, AUTOIMMUNE; RECEPTORS, CALCIUM-SENSING; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84895783717     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3723     Document Type: Article

References (36)

1. Zuklys S, Balciunaite G, Agarwal A, Fasler-Kan E, Palmer E, Holländer GA. Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune- polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Immunol. 2000;165:1976-1983. (Pubitemid 30648747)
2. Nagamine K, Peterson P, Scott HS, et al. Positional cloning of the APECED gene. Nat Genet. 1997;17:393-398. (Pubitemid 27518386)
3. The Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997;17:399-403.
4. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2006;91:2843-2850. (Pubitemid 44271722)
5. Söderbergh A, Myhre AG, Ekwall O, et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 2004;89:557-562. (Pubitemid 38269857)
6. Kisand K, Link M, Wolff AS, et al. Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. Blood. 2008;112:2657-2666.
7. Puel A, Döffinger R, Natividad A, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010;207:291-297.
8. Meager A, Peterson P, Willcox N. Hypothetical review: thymic aberrations and type I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes. Clin Exp Immunol. 2008;154:141-151.
9. Alimohammadi M, Björklund P, Hallgren A, et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med. 2008;358:1018-1028. (Pubitemid 351347101)
10. Li Y, Song YH, Rais N, et al. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest. 1996;97:910-914. (Pubitemid 26070569)
11. Gylling M, Kääriäinen E, Väisänen R, et al. The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protective effect of male sex. J Clin Endocrinol Metab. 2003;88:4602-4608. (Pubitemid 37357500)
12. Mayer A, Ploix C, Orgiazzi J, et al. Calcium-sensing receptor auto-antibodies are relevant markers of acquired hypoparathyroidism. J Clin Endocrinol Metab. 2004;89:4484-4488. (Pubitemid 39244459)
13. Gavalas NG, Kemp EH, Krohn KJE, Brown EM, Watson PF, Weetman AP. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab. 2007;92:2107-2114. (Pubitemid 46997107)
14. Ahonen P, Myallarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Eng J Med. 1990;322:1829-1836. (Pubitemid 20200407)
15. Oftedal BE, Kämpe O, Meager A, et al. Measuring autoantibodies against IL-17F and IL-22 in autoimmune polyendocrine syndrome type I by radioligand binding assay using fusion proteins. Scand J Immunol. 2011;74:327-333.
16. Wolff AS, Erichsen MM, Meager A, et al. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab. 2007;92:595-603.
17. Meager A, Visvalingam K, Peterson P, et al. Anti-interferon auto-antibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 2006;3:e289.
18. Tomar N, Kaushal E, Das M, Gupta N, Betterle C, Goswami R. Prevalence and significance of NALP5 autoantibodies in patients with idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 2012;97:1219-1226.
19. Cervato S, Morlin L, Albergoni MP, et al. AIRE gene mutations and autoantibodies to interferon omega in patients with chronic hypoparathyroidism without APECED. Clin Endocrinol (Oxf). 2010; 73:630-636.
20. 2+-sensing receptor from bovine parathyroid. Nature. 1993;366:575-580.
21. Tomar N, Gupta N, Goswami R. Calcium-sensing receptor auto-antibodies in idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 2013;98:3884-3891.
22. Ekwall O, Hedstrand H, Grimelius L, et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet. 1998;352:279-283. (Pubitemid 28340146)
23. Dal Pra C, Chen S, Betterle C, et al. Autoantibodies to human tryptophan hydroxylase and aromatic L-amino acid decarboxylase. Eur J Endocrinol. 2004;150:313-321. (Pubitemid 38443781)
24. Kössling FK, Emmrich P. Demonstration eines falles von Kindlichem morbus Addison mit hypoparathyreoidismus. Verh Dtsch Ges Pathol. 1971;55:155-160.
25. Van de Casseye M, Gepts W. Primary (autoimmune?) parathyroiditis. Virchows Arch A Path Anat. 1973;361:257-261.
26. Wortsman J, McConnachie P, Baker JR Jr, Mallette LE. T-lymphocyte activation in adult-onset idiopathic hypoparathyroidism. Am J Med. 1992;92:352-356.
27. Hermitte L, Atlan-Gepner C, Mattei C, et al. Diverging evolution of anti-GAD and anti-IA-2 antibodies in long-standing diabetes mellitus as a function of age at onset: no association with complications. Diabet Med. 1998;15:586-591. (Pubitemid 28319941)
28. Liblau RS, Singer SM, McDevitt HO. Thl and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune disease. Immunol Today. 1995;16:34-38.
29. Fattorossi A, Aurbach GD, Sakaguchi K, et al. Anti-endothelial cell antibodies: detection and characterization in sera from patients with autoimmune hypoparathyroidism. Proc Natl Acad Sci USA. 1988;85:4015-4019.
30. Betterle C, Caretto A, Zeviani M, Pedini B, Salviati C. Demonstration and characterization of anti-human mitochondria autoantibodies in idiopathic hypoparathyroidism and in other conditions. Clin Exp Immunol. 1985;62:353-360. (Pubitemid 15246906)
31. Brandi ML, Aurbach GD, Fattorossi A, Quarto R, Marx SJ, Fitzpatrick LA. Antibodies to bovine parathyroid cells in autoimmune hypoparathyroidism. Proc Natl Acad Sci USA. 1986;83:8366-8369. (Pubitemid 17182501)
32. Posillico JT, Wortsman J, Srikanta S, Eisenbarth GS, Mallette LE, Brown EM. Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res. 1986;1:475-483.
33. Morgenthaler NG, Ho SC, Minich WB. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites. J Clin Endocrinol Metab. 2007;92:1058-1065. (Pubitemid 46465683)
34. Jacob S, Viegas S, Leite MI, et al. Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis. Arch Neurol. 2012;69:994-1001.
35. Kemp EH, Gavalas NG, Krohn KJE, Brown EM, Watson PF, Weetman AP. Activating autoantibodies against the calcium-sensing receptor in two patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab. 2009;94:4749-4756.
36. Kifor O, McElduff A, LeBoff MS, et al. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism. J Clin Endocrinol Metab. 2004;89:548-556. (Pubitemid 38269856)